Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,214 | -490,874 | -348,647 | -225,710 | -107,290 |
| Depreciation Amortization | 3,178 | 11,898 | 9,653 | 6,066 | 3,000 |
| Accounts receivable | -16,766 | -10,668 | 8,690 | 7,929 | 3,877 |
| Accounts payable and accrued liabilities | -9,042 | 26,629 | -17,271 | -8,326 | -11,067 |
| Other Working Capital | -38,154 | -2,902 | -10,687 | -5,058 | -14,465 |
| Other Operating Activity | 46,334 | 83,131 | 78,520 | 43,720 | 25,615 |
| Operating Cash Flow | $-155,664 | $-382,786 | $-279,742 | $-181,379 | $-100,330 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -113,557 | -306,152 | -46,292 | 65,208 | 111,228 |
| PPE Investments | -21,257 | -104,209 | -83,481 | -57,803 | -36,152 |
| Purchase Of Investment | N/A | 120,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-134,814 | $-290,361 | $-129,773 | $7,405 | $75,076 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -120,000 | N/A | N/A | N/A |
| Common Stock Issued | 42,094 | 1,244,891 | 418,131 | 389,175 | 2,769 |
| Common Stock Repurchased | -572 | N/A | -188 | -147 | -53 |
| Financing Cash Flow | $41,522 | $1,124,891 | $417,943 | $389,028 | $2,716 |
| Beginning Cash Position | 646,832 | 195,088 | 195,088 | 195,088 | 195,088 |
| End Cash Position | 397,876 | 646,832 | 203,516 | 410,142 | 172,550 |
| Net Cash Flow | $-248,956 | $451,744 | $8,428 | $215,054 | $-22,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -155,664 | -382,786 | -279,742 | -181,379 | -100,330 |
| Capital Expenditure | -21,257 | -104,209 | -83,481 | -57,803 | -36,152 |
| Free Cash Flow | -176,921 | -486,995 | -363,223 | -239,182 | -136,482 |